• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


5.2200 USD 0.0300 0.57%

As of 17:20:00 ET on 07/25/2014.

Snapshot for Alliqua Inc (ALQA)

Open: 5.2650 Day's Range: 5.1100 - 5.4300 Volume: 26,796
Previous Close: 5.2500 52wk Range: 2.6305 - 10.1100 1-Yr Rtn: +59.09%

Stock Chart for ALQA

No chart data available.
  • ALQA:US 5.2200
  • 1D
  • 1M
  • 1Y
Interactive ALQA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALQA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.7150
Est. EPS (USD) (12/2014) -1.6400
Est. PEG Ratio -
Market Cap (M USD) 82.15
Shares Outstanding (M) 15.74
30 Day Average Volume 44,047
Price/Book (mrq) 5.8161
Price/Sale (ttm) 21.7403
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALQA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ALQA

Alliqua Inc. operates as a biomedical company. The Company focuses on the development, manufacturing, and distribution of transdermal wound care and drug delivery technologies, including its technology platform for producing hydrogels. Alliqua offers its products to the healthcare industry, including wound healing, medical diagnostics, and cosmeceuticals.

David I Johnson "Dave"President/CEOBrian M PosnerCFO/Treasurer/Secretary
Lori TonerChief Marketing OfficerJanice M SmiellChief Medical Officer
More Company Profile & Key Executives for ALQA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil